Join the Hypertriglyceridemia group to help and get support from people like you.
Hypertriglyceridemia News
Related terms: High Triglycerides
Hypercholesterolemia Treatment Falls Short of Guidelines
THURSDAY, July 10, 2025 – Pharmacologic treatment of hypercholesterolemia falls short of U.S. and European guidelines, according to a study published online June 30 in the Journal of General...
Tens Of Thousands of Heart Attacks, Strokes Could Be Prevented With Cholesterol Lowering Medications
WEDNESDAY, July 2, 2025 — Tens of thousands of people suffer needless heart attacks and strokes every year because they aren’t taking cholesterol-lowering drugs, a new study says. More than 39,000 dea...
Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease
MONDAY, June 30, 2025 – For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the triglyceride-glucose (TyG) index experience...
Two-Drug Combo of a Statin Plus Ezetimibe, Lowers Cholesterol Better Than Statins Alone
TUESDAY, March 25, 2025 – Statins are very cheap and highly effective cholesterol-lowering drugs – but high-risk heart patients may have an even better option, a new evidence review says. Combining...
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
FRIDAY, Feb. 21, 2025 – Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a]) production, leads to a significant and sustained reduction in oxidized phospholipids (OxPL) on...
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk
MONDAY, Nov. 25, 2024 – Muvalaplin reduces lipoprotein(a) levels, according to a study published online Nov. 20 in the Journal of the American Medical Association to coincide with the American Heart...
Prevalence of High Total Cholesterol 11.3 Percent in U.S. Adults
WEDNESDAY, Nov. 20, 2024 – The prevalence of high total cholesterol was 11.3 percent among U.S. adults in August 2021 to August 2023, according to a November data brief published by the National...
Statin Therapy Cost-Effectively Improves Health Outcomes for ≥70s
THURSDAY, Sept. 12, 2024 – Statin therapy improves health outcomes and is cost-effective for men and women aged 70 years and older, according to a study published online Sept. 10 in Heart. Borislava...
Can Non-Statin Cholesterol Meds Help Your Liver?
WEDNESDAY, July 31, 2024 – Prior studies have found that statin meds can help lower liver cancer risks, and new research suggests that at least one non-statin cholesterol drug can do the same. A...
FDA Approves Epanova for Severe Hypertriglyceridemia
Tuesday, 6 May 2014 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Epanova (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels...
Amarin Announces FDA Approval of Vascepa (icosapent ethyl) Capsules for the Reduction of Triglyceride Levels in Adult Patients With Severe Hypertriglyceridemia
BEDMINSTER, N.J. and DUBLIN, Ireland, July 26, 2012 – Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular...